Antibiotic-induced gut microbiota disruption promotes vascular calcification by reducing short-chain fatty acid

Shi-Yu Zeng1, Yi-Fu Liu2,3, Zhao-Lin Zeng1

  • 1Department of Metabolism and Endocrinology, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, 421001, Hunan, China.

Abstract

Insights

Antibiotics worsen vascular calcification by disrupting gut bacteria and short-chain fatty acids (SCFAs). Acetate supplementation may alleviate this condition, offering a potential therapeutic target for vascular calcification.

Area of Science:

  • Cardiovascular Research
  • Microbiome Science
  • Metabolic Studies

Background:

  • Vascular calcification is a significant risk factor for cardiovascular events.
  • Antibiotics can alter the gut microbiota (GM), but their impact on vascular calcification is not well understood.

Purpose of the Study:

  • To investigate the effect of antibiotic-induced GM disruption on vascular calcification.
  • To explore the potential of short-chain fatty acids (SCFAs), specifically acetate, in mitigating vascular calcification.

Main Methods:

  • Antibiotic cocktail (ABX) and vancomycin treatments were administered to mice to induce GM disruption.
  • 16S rRNA gene sequencing and targeted metabolomics were used to analyze GM composition and serum SCFA levels.
  • Proteomics was employed to elucidate the mechanism of acetate's action on vascular smooth muscle cells (VSMCs).

Main Results:

  • Antibiotic treatments exacerbated vascular calcification, correlating with reduced Bacteroidetes abundance and lower serum SCFA levels.
  • Acetate supplementation reduced aortic calcium deposition and inhibited VSMC osteogenic transformation.
  • Acetate's inhibitory effect on VSMCs involves glutathione metabolism, as evidenced by BSO intervention.

Conclusions:

  • Antibiotic-induced gut dysbiosis, characterized by reduced Bacteroidetes and SCFAs, exacerbates vascular calcification.
  • Acetate emerges as a potential therapeutic agent for vascular calcification, targeting VSMC osteogenic transformation.

Related Concept Videos

Factors Influencing Drug Absorption: Disease States and Pharmacology01:25

Factors Influencing Drug Absorption: Disease States and Pharmacology

Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
468
Bacterial Flora of the Large Intestine01:29

Bacterial Flora of the Large Intestine

The gut microbiome is formed by a vast and diverse community of bacteria that colonizes our large intestine. These bacteria start residing in the gut from birth and continue diversifying throughout life, influenced by factors such as diet, lifestyle, and stress. The gut bacterial community also includes bacteria from food and those that enter the colon through the anus.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
401
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
111
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
329
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
358
Anatomy of the Intestines01:23

Anatomy of the Intestines

Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
71.6K